Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2013, Article ID 429037, 8 pages
http://dx.doi.org/10.1155/2013/429037
Research Article

Circadian Models of Serum Potassium, Sodium, and Calcium Concentrations in Healthy Individuals and Their Application to Cardiac Electrophysiology Simulations at Individual Level

1Department of Statistics, Cracow University of Economics, 27 Rakowicka Street, 31-510 Krakow, Poland
2Department of Oncology, Jagiellonian University Medical College, 20 Grzegorzecka Street, 31-531 Krakow, Poland
3Unit of Pharmacoepidemiology and Pharmacoeconomics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 Street, 30-688 Krakow, Poland

Received 27 May 2013; Accepted 25 July 2013

Academic Editor: Michele Migliore

Copyright © 2013 Kamil Fijorek et al. This is an open access article, distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Ohdo, S. Koyanagi, and N. Matsunaga, “Chronopharmacological strategies: intra- and inter-individual variability of molecular clock,” Advanced Drug Delivery Reviews, vol. 62, no. 9-10, pp. 885–897, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Takeda and K. Maemura, “Cardiovascular disease, chronopharmacotherapy, and the molecular clock,” Advanced Drug Delivery Reviews, vol. 62, no. 9-10, pp. 956–966, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Sukumaran, R. R. Almon, D. C. DuBois, and W. J. Jusko, “Circadian rhythms in gene expression: relationship to physiology, disease, drug disposition and drug action,” Advanced Drug Delivery Reviews, vol. 62, no. 9-10, pp. 904–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Okamura, M. Doi, J. M. Fustin, Y. Yamaguchi, and M. Matsuo, “Mammalian circadian clock system: molecular mechanisms for pharmaceutical and medical sciences,” Advanced Drug Delivery Reviews, vol. 62, no. 9-10, pp. 876–884, 2010. View at Publisher · View at Google Scholar
  5. S. Fournier, E. Eeckhout, F. Mangiacapra et al., “Circadian variations of ischemic burden among patients with myocardial infarction undergoing primary percutaneous coronary intervention,” American Heart Journal, vol. 163, no. 2, pp. 208–213, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Panda and J. B. Hogenesch, “It's all in the timing: many clocks, many outputs,” Journal of Biological Rhythms, vol. 19, no. 5, pp. 374–387, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Hoyer, B. Frank, R. Baranowski, J. Zebrowski, P. Stein, and H. Schmidt, “Autonomic information flow rhythms: from heat beat interval to circadian variation,” IEEE Engineering in Medicine and Biology Magazine, vol. 26, no. 6, pp. 19–24, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Stein, E. Lundequam, L. Oliveira et al., “Circadian and ultradian rhythms in cardiac autonomic modulation,” IEEE Engineering in Medicine and Biology Magazine, vol. 26, no. 6, pp. 14–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Albrecht and G. Eichele, “The mammalian circadian clock,” Current Opinion in Genetics and Development, vol. 13, no. 3, pp. 271–277, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Eckel-Mahan and P. Sassone-Corsi, “Epigenetic regulation of the molecular clockwork,” Progress in Molecular Biology and Translational Science, vol. 119, pp. 29–50, 2013. View at Publisher · View at Google Scholar
  11. D. J. Durgan and M. E. Young, “The cardiomyocyte circadian clock: emerging roles in health and disease,” Circulation Research, vol. 106, no. 4, pp. 647–658, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. D. J. Durgan, T. Pulinilkunnil, C. Villegas-Montoya et al., “Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock,” Circulation Research, vol. 106, no. 3, pp. 546–550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Watanabe, T. Arakawa, T. Uchiyama et al., “Prognostic significance of circadian variability of RR and QT intervals and QT dynamicity in patients with chronic heart failure,” Heart Rhythm, vol. 4, no. 8, pp. 999–1005, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Johansson and T. Partonen, “Human genetic studies in chronobiology,” in Trends in Chronobiology Research, F. H. Columbus, Ed., pp. 63–85, Nova Science Publishers, New York, NY, USA, 2006. View at Google Scholar
  15. E. Ferraz, M. C. Borges, and E. O. Vianna, “Influence of nocturnal asthma on chronotype,” Journal of Asthma, vol. 45, no. 10, pp. 911–915, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. P. Hidalgo, W. Caumo, M. Posser, S. B. Coccaro, A. L. Camozzato, and M. L. F. Chaves, “Relationship between depressive mood and chronotype in healthy subjects,” Psychiatry and Clinical Neurosciences, vol. 63, no. 3, pp. 283–290, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Wirz-Justice, F. Benedetti, and M. Terman, Chronotherapeutics for Affective Disorders: A Clinician's Manual for Light and Wake Therapy, Karger, Basel, Switzerland, 2012.
  18. B. B. Youan, Chronopharmaceutics: Science and Technology for Biological Rhythm-Guided Therapy and Prevention of Diseases, John Wiley & Sons, Hoboken, NJ, USA, 2009.
  19. S. L. Block, D. Kelsey, D. Coury et al., “Once-daily atomoxetine for treating pediatric attention-deficit/ hyperactivity disorder: comparison of morning and evening dosing,” Clinical Pediatrics, vol. 48, no. 7, pp. 723–733, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Lemmer, “Clinical chronopharmacology: the importance of time in drug treatment,” Ciba Foundation Symposium, vol. 183, pp. 235–247, 1995. View at Google Scholar · View at Scopus
  21. K. Erol, F. S. Kiliç, Ö. S. Batu, and E. Yildirim, “Morning-evening administration time differences in digoxin kinetics in healthy young subjects,” Chronobiology International, vol. 18, no. 5, pp. 841–849, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Nakano and L. E. Hollister, “Chronopharmacology of amitriptyline,” Clinical Pharmacology and Therapeutics, vol. 33, no. 4, pp. 453–459, 1983. View at Google Scholar · View at Scopus
  23. B. R. Rao and D. Rambhau, “Diurnal oscillations in the serum and salivary levels of quinidine,” Drug Research, vol. 45, no. 6, pp. 681–683, 1995. View at Google Scholar · View at Scopus
  24. A. Rostami-Hodjegan, “Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology,” Clinical Pharmacology & Therapeutics, vol. 92, pp. 50–61, 2012. View at Google Scholar
  25. K. H. W. J. Ten Tusscher, D. Noble, P. J. Noble, and A. V. Panfilov, “A model for human ventricular tissue,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 286, no. 4, pp. H1573–H1589, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. G. R. Mirams, M. R. Davies, Y. Cui, P. Kohl, and D. Noble, “Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing,” British Journal of Pharmacology, vol. 167, pp. 932–945, 2012. View at Google Scholar
  27. G. R. Mirams, Y. Cui, A. Sher et al., “Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk,” Cardiovascular Research, vol. 91, no. 1, pp. 53–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. J. D. Moreno, Z. I. Zhu, P.-C. Yang et al., “A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms,” Science Translational Medicine, vol. 3, no. 98, Article ID 98ra83, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Zemzemi, M. O. Bernabeu, J. Saiz et al., “Computational assessment of drug-induced effects on the electrocardiogram: from ion channel to body surface potentials,” British Journal of Pharmacology, vol. 168, pp. 718–733, 2013. View at Google Scholar
  30. C. Obiol-Pardo, J. Gomis-Tena, F. Sanz, J. Saiz, and M. Pastor, “A multiscale simulation system for the prediction of drug-induced cardiotoxicity,” Journal of Chemical Information and Modeling, vol. 51, no. 2, pp. 483–492, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Polak, K. Fijorek, A. Glinka, B. Wisniowska, and A. Mendyk, “Virtual population generator for human cardiomyocytes parameters: in silico drug cardiotoxicity assessment,” Toxicology Mechanisms and Methods, vol. 22, no. 1, pp. 31–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Polak and K. Fijorek, “Inter-individual variability in the pre-clinical drug cardiotoxic safety assessment—analysis of the age—cardiomyocytes electric capacitance dependence,” Journal of Cardiovascular Translational Research, vol. 5, pp. 321–332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Fijorek, N. Patel, Ł. Klima, K. Stolarz-Skrzypek, K. Kawecka-Jaszcz, and S. Polak, “Age and gender dependent heart rate circadian model development and performance verification on the proarrhythmic drug case study,” Theoretical Biology and Medical Modelling, vol. 10, article 7, 2013. View at Google Scholar
  34. S. Polak, K. Fijorek, M. Puskulluoglu, A. Glinka, D. Tomaszewska, and R. Tomaszewski, “Literature review of the serum potassium, sodium and calcium levels in healthy individuals,” Technical Note 001, 2013, http://tox-portal.net. View at Google Scholar
  35. F. Ceriotti, J. Henny, J. Queraltó et al., “Common reference intervals for aspartate aminotransferase (AST), alanine aminotransferase (ALT) and γ-glutamyl transferase (GGT) in serum: results from an IFCC multicenter study,” Clinical Chemistry and Laboratory Medicine, vol. 48, no. 11, pp. 1593–1601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Kratz and K. B. Lewandrowski, “Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values,” The New England journal of medicine, vol. 339, no. 15, pp. 1063–1072, 1998. View at Google Scholar · View at Scopus
  37. M. E. Markowitz, J. F. Rosen, S. Laxminarayan, and M. Mizruchi, “Circadian rhythms of blood minerals during adolescence,” Pediatric Research, vol. 18, no. 5, pp. 456–462, 1984. View at Google Scholar · View at Scopus
  38. H. P. Sennels, H. L. Jørgensen, J. P. Goetze, and J. Fahrenkrug, “Rhythmic 24-hour variations of frequently used clinical biochemical parameters in healthy young males–the Bispebjerg study of diurnal variations,” Scandinavian Journal of Clinical & Laboratory Investigation, vol. 72, pp. 287–295, 2012. View at Google Scholar
  39. M. Bernardi, R. DePalma, and F. Trevisani, “Serum potassium circadian rhythm. Relationship with aldosterone,” Hormone and Metabolic Research, vol. 17, no. 12, p. 695, 1985. View at Google Scholar · View at Scopus
  40. R. B. Sothern, D. L. Vesely, E. L. Kanabrocki et al., “Circadian relationships between circulating atrial natriuretic peptides and serum sodium and chloride in healthy humans,” American Journal of Nephrology, vol. 16, no. 6, pp. 462–470, 1996. View at Google Scholar · View at Scopus
  41. E. L. Kanabrocki, L. E. Scheving, and F. Halberg, “Circadian variations in presumably healthy men under conditions of peace time army reserve unit training,” Space Life Sciences, vol. 4, no. 2, pp. 258–270, 1973. View at Google Scholar · View at Scopus
  42. S. P. Hozo, B. Djulbegovic, and I. Hozo, “Estimating the mean and variance from the median, range, and the size of a sample,” BMC Medical Research Methodology, vol. 5, article 13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. E. L. Kanabrocki, R. B. Sothern, L. E. Scheving et al., “Ten-year-replicated circadian profiles for 36 physiological, serological and urinary variables in healthy men,” Chronobiology International, vol. 5, no. 3, pp. 237–284, 1988. View at Google Scholar · View at Scopus
  44. G. H. Williams, J. P. Cain, R. G. Dluhy, and R. H. Underwood, “Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading,” Journal of Clinical Investigation, vol. 51, no. 7, pp. 1731–1742, 1972. View at Google Scholar · View at Scopus
  45. W. Jubiz, J. M. Canterbury, E. Reiss, and F. H. Tyler, “Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels,” Journal of Clinical Investigation, vol. 51, no. 8, pp. 2040–2046, 1972. View at Google Scholar · View at Scopus
  46. M. R. Wills, “The effect of diurnal variation on total plasma calcium concentration in normal subjects,” Journal of Clinical Pathology, vol. 23, no. 9, pp. 772–777, 1970. View at Google Scholar · View at Scopus
  47. J. Molnar, F. Zhang, J. Weiss, F. A. Ehlert, and J. E. Rosenthal, “Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events,” Journal of the American College of Cardiology, vol. 27, no. 1, pp. 76–83, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Ishida, M. Nakagawa, T. Fujino, H. Yonemochi, T. Saikawa, and M. Ito, “Circadian variation of QT interval dispersion: correlation with heart rate variability,” Journal of Electrocardiology, vol. 30, no. 3, pp. 205–210, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. V. K. Yeragani, R. Berger, R. Pohl, and R. Balon, “Effect of age on diurnal changes of 24-hour QT interval variability,” Pediatric Cardiology, vol. 26, no. 1, pp. 39–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. B.-B. C. Youan, “Chronopharmaceutical drug delivery systems: hurdles, hype or hope?” Advanced Drug Delivery Reviews, vol. 62, no. 9-10, pp. 898–903, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. R. C. Hermida, D. E. Ayala, A. Mojón, and J. R. Fernández, “Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk,” Chronobiology International, vol. 30, pp. 328–339, 2013. View at Google Scholar